SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industries, today announced results for its fiscal 2014 first quarter.
Commenting on the Company’s performance, SurModics’ President and Chief Executive Officer, Gary Maharaj said, “Our first quarter financial results reflect solid pro forma revenue and earnings per share growth even in a challenging market environment.
Help employers find you! Check out all the jobs and post your resume.
